Basics |
Surmodics, Inc.
Surmodics Inc is a provider of surface modification and in vitro diagnostic technologies to the healthcare industry.
|
IPO Date: |
March 4, 1998 |
Sector: |
Healthcare |
Industry: |
Health Care Equipment and Supplies |
Market Cap: |
$462.96M |
Activated in VL: |
True |
Average Daily Range |
Avg Daily Range: |
$0.50 | 1.61%
|
Avg Daily Range (30 D): |
$0.63 | 1.78%
|
Avg Daily Range (90 D): |
$0.47 | 1.48%
|
Institutional Daily Volume |
Avg Daily Volume: |
.1M |
Avg Daily Volume (30 D): |
.29M |
Avg Daily Volume (90 D): |
.14M |
Trade Size |
Avg Trade Size (Sh.): |
119 |
Avg Trade Size (Sh.) (30 D): |
80 |
Avg Trade Size (Sh.) (90 D): |
72 |
Institutional Trades |
Total Inst.Trades: |
1,739 |
Avg Inst. Trade: |
$1.71M |
Avg Inst. Trade (30 D): |
$.97M |
Avg Inst. Trade (90 D): |
$1.05M |
Avg Inst. Trade Volume: |
.05M |
Avg Inst. Trades (Per Day): |
1 |
Market Closing Trades |
Avg Closing Trade: |
$1.29M |
Avg Closing Trade (30 D): |
$.68M |
Avg Closing Trade (90 D): |
$.84M |
Avg Closing Volume: |
36.61K |
|
|
Financials |
|
TTM |
Q3 2025 |
Q2 2025 |
Basic EPS
|
|
$-.37
|
$-.36
|
Diluted EPS
|
|
$-.37
|
$-.36
|
Revenue
|
$
|
$ 29.57M
|
$ 28.09M
|
Gross Profit
|
$
|
$ 20.99M
|
$ 20.26M
|
Net Income / Loss
|
$
|
$ -5.32M
|
$ -5.21M
|
Operating Income / Loss
|
$
|
$ -5.24M
|
$ -4.01M
|
Cost of Revenue
|
$
|
$ 8.58M
|
$ 7.83M
|
Net Cash Flow
|
$
|
$ -3.56M
|
$ -1.28M
|
PE Ratio
|
|
|
|
|
|
|